LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
289
via globenewswire.comBusiness & Companies

Can-Fite Completes Dosing of All Patients in Phase III Psoriasis Study

FROM THE WIRE · GLOBENEWSWIRE.COM

The study evaluates oral Piclidenoson and last patient in the interim-analysis cohort completes treatment Ramat Gan, Israel, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralClinical trial milestone for a small biotech, with potential impact on the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01All 247 patients in the Phase III study of a small molecule have completed treatment.
  2. 02The study evaluates Piclidenoson for moderate-to-severe plaque psoriasis.
  3. 03The interim analysis is expected in Q1 2027.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.